Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIMCERE PHARMA

14.270
+0.2501.78%
Volume:3.62M
Turnover:51.44M
Market Cap:37.04B
PE:44.65
High:14.340
Open:13.990
Low:13.800
Close:14.020
52wk High:15.080
52wk Low:6.050
Shares:2.60B
HK Float Shares:2.60B
Volume Ratio:3.14
T/O Rate:0.14%
Dividend:0.18
Dividend Rate:1.23%
EPS(LYR):0.320
ROE:12.45%
ROA:6.50%
PB:4.68
PE(LYR):44.65
PS:4.76

Loading ...

Simcere Pharmaceutical Group Ltd. Completes Placing of Existing Shares and Top-Up Subscription of New Shares

Reuters
·
Sep 10

From "Import" to "Local Production": SIMCERE PHARMA (02096) Leverages Free Trade Port Policies to Build Comprehensive Innovation Drug Industry Chain

Stock News
·
Sep 10

BRIEF-Simcere Pharmaceutical Group Says SIM0609 Obtains Clinical Trial Approval In China By NMPA

Reuters
·
Sep 08

Simcere Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Sep 08

SIMCERE PHARMA (02096): SIM0609 (CDH17 Antibody-Drug Conjugate) Receives Clinical Trial Approval from National Medical Products Administration

Stock News
·
Sep 08

Simcere Pharmaceutical Group Announces Clinical Trial Approval for Innovative Anti-Tumor Drug SIM0609

Reuters
·
Sep 08

Simcere Pharmaceutical Group - Sim0609 Obtains Clinical Trial Approval in China NY Nmpa

THOMSON REUTERS
·
Sep 08

Simcere Pharmaceutical Group Ltd. and Jiaxing AnDiCon Biotech Co., Ltd. Secure Acceptance of New Drug Application for Deunoxavir Marboxil Granules by National Medical Products Administration

Reuters
·
Sep 03

SIMCERE PHARMA (02096): New Drug Application (NDA) for Martenoxavir Granules Accepted by National Medical Products Administration

Stock News
·
Sep 03

Simcere Pharmaceutical - New Drug Application of Deunoxavir Marboxil Accepted by China's Nmpa for Pediatric Use

THOMSON REUTERS
·
Sep 03

SIMCERE PHARMA (02096): Accelerating Global Value Creation with HK$1.5+ Billion Placement Signaling Long-term Investment Confidence

Stock News
·
Sep 03

Simcere Pharma to Raise Nearly HK$1.6 Billion via Share Placement, Top-Up Subscription

MT Newswires Live
·
Sep 02

BUZZ-Simcere Pharmaceutical falls most in 2-1/2 months on discounted share sale

Reuters
·
Sep 02

BRIEF-Simcere Pharmaceutical To Issue 121 Million Subscription Shares

Reuters
·
Sep 02

Simcere Pharmaceutical - to Issue 121 Mln Subscription Shares at HK$12.95 per Share

THOMSON REUTERS
·
Sep 02

Hong Kong Stock Movement | SIMCERE PHARMA (02096) Surges Over 6% in Morning Session, H1 Revenue Grows Over 15% with Innovative Drug Revenue Share Exceeding Three-Quarters for First Time

Stock News
·
Aug 29

BRIEF-Simcere Pharmaceutical Says Unit To Buy Entire Assets Of Sanroad Shanghai For RMB17.5 Mln

Reuters
·
Aug 26

SIMCERE PHARMA (02096) Plans RMB 83.18 Million Acquisition of Shanghai Xiangrui Assets and Xianwei Equity to Rapidly Enter mRNA Technology Sector

Stock News
·
Aug 26

Simcere Pharmaceutical - Unit to Acquire Entire Assets of Sanroad Shanghai for RMB17.5 Mln, Others

THOMSON REUTERS
·
Aug 26

Hong Kong Stocks Movement | SIMCERE PHARMA (02096) Surges Over 6% Again, Strong H1 Innovation R&D Results, Dalirexant Expected to Launch Officially This Year

Stock News
·
Aug 25